How do hospitals ensure they are meeting the needs of vulnerable populations within the communities that they serve
The340B Drug Pricing Programis aprogram created in 1992 that requires drug manufacturers to provide outpatient drugs to eligible health care organizations and covered entities at significantly reduced prices. The intent of the program is to allow covered entities to “stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services.”Maintaining services and lowering medication costs for patients is consistent with the purpose of the program, which is named for the section authorizing it in the(PHSA) It was enacted by Congress as part of a larger bill signed into law
created thein 1990. It required pharmaceutical manufacturers to provide rebates for medication purchases, based on sales to Medicaid beneficiaries, as a condition of having their products covered by Medicaid.The amount of the rebates paid to the states were based on a “best price” calculation that did not take into account the discounted prices that manufacturers were offering directly to Federally funded clinics and public hospitals serving large numbers of low-income and uninsured patients.